CD44 and cancer: Significantly, the CD44+/CD24−/Low subpopulation revealed higher centrosome amplification compared to bulk SUM149PT cancer cells (Fig. 2B and C), suggesting that the higher degree of CIN observed in SUM149PT cancer cells was functionally linked to the genesis of CD44+/CD24−/Low CSCs harboring amplified centrosomes.